SCHEMBL6624216

SCHEMBL6624216

COc1cc(-n2ccc(C)n2)ccc1C(=O)O.O=C(Cl)Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
HTT P42858 1/20 0.42
AVPR2 P30518 6/20 0.41
F2 P00734 1/20 0.40
PLAU P00749 1/20 0.40
KLKB1 P03952 1/20 0.40
ELANE P08246 1/20 0.40
SIRT5 Q9NXA8 1/20 0.40
KAT6A Q92794 1/20 0.40
OXTR P30559 2/20 0.39
AVPR1A P37288 2/20 0.39
HPGD P15428 2/20 0.39
HDAC4 P56524 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
MYC P01106 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6624777 0.96 ALDH1A1 (0.48) ALDH1A1HTTAVPR2F2PLAU
SCHEMBL6624218 0.85 AVPR2 (0.39) ALDH1A1HTTAVPR2F2PLAU
SCHEMBL6626130 0.84 KMT2A (0.45) ALDH1A1HTTAVPR2F2PLAU
SCHEMBL3811575 0.80 MYC (0.57) ALDH1A1HTTAVPR2KAT6AOXTR
SCHEMBL17158243 0.79 KAT6A (0.46) ALDH1A1HTTAVPR2KLKB1ELANE
SCHEMBL6614088 0.75 AVPR2 (0.51) ALDH1A1HTTAVPR2KAT6AAVPR1A
SCHEMBL5064726 0.75 ALDH1A1 (0.48) ALDH1A1HTTKAT6AHPGDKDM4E
SCHEMBL20462877 0.74 KAT6A (0.61) ALDH1A1HTTAVPR2KAT6AHDAC4
SCHEMBL6611595 0.74 AVPR2 (0.55) ALDH1A1HTTAVPR2KAT6AOXTR
SCHEMBL3821527 0.74 AVPR2 (0.52) ALDH1A1AVPR2KAT6AOXTRAVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6831079-B1 Oral delivery; nitrogen triheterocyclic active material, surfactant, polyethylene glycol with sucrose fatty acid esters and/or polyvinylpyrrolidone AMERICAN CYANAMID COMPANY 2004-12-14 US disclosed
EP-1000062-B1 TRICYCLIC VASOPRESSIN AGONISTS WYETH CORP (US) 2004-09-22 EP disclosed
US-6511974-B1 Non-peptidic and have good oral bioavailability, specific vasopressin V2 agonists, therefore do not raise blood pressure WYETH 2003-01-28 US disclosed